Skip to main content
Springer logoLink to Springer
. 2024 Nov 21;19(1):118. doi: 10.1007/s11657-024-01478-0

Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials

Mingnian Li 1, Zhuoqi Ge 2, Benqi Zhang 1, Li Sun 2, Zhongyuan Wang 2, Tao Zou 3, Qi Chen 1,2,
PMCID: PMC11579120  PMID: 39567458

Correction: Archives of Osteoporosis (2024) 19:89

10.1007/s11657-024-01447-7

In this article the affiliation details for Author Mingnian Li were incorrectly given as 'Department of Pharmacy, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China' but should have been 'College of Pharmacy, Guizhou Medical University, Guiyang, Guizhou, China'.

The corrected affiliation details are as follows:

Mingnian Li1 · Zhuoqi Ge2 · Benqi Zhang1 · Li Sun2 · Zhongyuan Wang2 · Tao Zou3 · Qi Chen1,2

1 College of Pharmacy, Guizhou Medical University, Guiyang, Guizhou, China.

2 Department of Pharmacy, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China.

3 Department of Pharmacy, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, Guizhou, China.

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Archives of Osteoporosis are provided here courtesy of Springer

RESOURCES